Full Year 2023 Guidance
- Ginkgo expects to add 100 new Cell Programs to the Foundry platform in 2023
- Ginkgo expects Total revenue of at least $275 million in 2023
- Ginkgo expects Foundry revenue of at least $175 million in 2023. This guidance excludes the impact of any downstream value share revenue, although Ginkgo is still working toward the achievement of downstream value share in 2023
- While Biosecurity remains an uncertain business, Ginkgo expects Biosecurity revenue in 2023 of at least $100 million, with nearly half of this revenue expected to come from emerging product lines that are more recurring in nature, such as federal and international partnerships supporting pathogen monitoring and biosecurity infrastructure development
Timing of Filing Annual Report on Form 10-K